C. Chesnut

发表

In Vivo Assessment of Architecture and Micro-Finite Element Analysis Derived Indices of Mechanical Properties of Trabecular Bone in the Radius

S. Majumdar, H. Genant, B. van Rietbergen, 2002, Osteoporosis International.

Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study

D. Newitt, E. Eriksen, C. Chesnut, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation

T A Einhorn, C C Johnston, S. Silverman, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

H K Genant, Jacques P. Brown, H. Genant, 1999, JAMA.

Ability of four different techniques of measuring bone mass to diagnose vertebral fractures in postmenopausal women

R F Kilcoyne, S. Ott, C. Chesnut, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long-term calcitonin therapy in postmenopausal osteoporosis.

W. Nelp, H. Gruber, C. Chesnut, 1984, Metabolism: clinical and experimental.

Basal plasma immunoreactive calcitonin in postmenopausal osteoporosis.

W. Nelp, B. Roos, C. Chesnut, 1980, Metabolism: clinical and experimental.

DEFICIENT CALCITONIN RESPONSE TO CALCIUM STIMULATION IN POSTMENOPAUSAL OSTEOPOROSIS?

B. Roos, C. Chesnut, D. Baylink, 1982, The Lancet.

Oral findings in osteoporosis. Part I: Measurement of mandibular bone density.

D. E. Smith, C. Chesnut, P. Kribbs, 1983, The Journal of prosthetic dentistry.

The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.

C. Rosen, C. Chesnut, N. Mallinak, 1997, The Journal of clinical endocrinology and metabolism.

Bone density at multiple skeletal sites in amenorrheic athletes.

B. Drinkwater, C. Chesnut, M. Rencken, 1996, JAMA.

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross‐linked collagen peptides in urine

H. Genant, D. Eyre, B. Gertz, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Biological Variability of Serum and Urinary N‐Telopeptides of Type I Collagen in Postmenopausal Women

R. Eastell, M. Pettinger, M. Ettinger, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

An Appraisal of the Role of Estrogens in the Treatment of Postmenopausal Osteoprosis

C. Chesnut, 1984, Journal of the American Geriatrics Society.

Review of Treatment Modalities for Postmenopausal Osteoporosis

N. Watts, M. Holick, M. Maricic, 2005, Southern medical journal.

Clinical Utilization of Salmon Calcitonin in the Treatment of Osteoporosis

C. Chesnut, M. Azria, 2003 .

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

D. Kiel, S. Silverman, H. Genant, 2000, The American journal of medicine.

Salmon Calcitonin: An Update on Its Clinical Utility in Osteoporosis

C. Chesnut, M. Azria, 2010 .

History of calcitonin

C. Chesnut, 2002, The Lancet.

Assessment of bone quality, quantity, and turnover with multiple methodologies at multiple skeletal sites.

S. Majumdar, D. Newitt, C. Chesnut, 2001, Advances in experimental medicine and biology.

Osteoporosis, an underdiagnosed disease.

C. Chesnut, 2001, JAMA.

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.

B. Storer, C. Chesnut, J. Sanders, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data

R. Rizzoli, S. Boonen, M. Meredith, 2005, Aging clinical and experimental research.

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

H. Genant, N. Watts, R. Jackson, 1993, The American journal of medicine.

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis

Jacques P. Brown, C. Christiansen, J. Adachi, 2010, BMC musculoskeletal disorders.

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women.

H. Genant, D. Eyre, B. Gertz, 1993, The Journal of clinical endocrinology and metabolism.

Osteoporosis and its treatment.

C. Chesnut, 1992, The New England journal of medicine.

7 Do we have any alternative to sex steroids in the prevention and treatment of osteoporosis

C. Chesnut, 1991 .

Exacerbation of rheumatoid arthritis by sodium fluoride treatment of osteoporosis.

C. Chesnut, P. Duell, 1991, Archives of internal medicine.

Chronic intermittent cyclical administration of tiludronate in postmenopausal osteoporosis: report of two multicenter studies in 2136 patients

H. Genant, J. Eisman, R. Recker, 1998 .

Diagnosis of Postmenopausal Osteoporosis: Reviews in Endocrine and Metabolic Disorders

C. Chesnut, A. Shields, 2004, Reviews in Endocrine and Metabolic Disorders.

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study

R. Recker, R. Weinstein, P. Meunier, 2004, Osteoporosis International.

Assessment Results From the National Osteoporosis Risk Low Bone Mineral Density in Postmenopausal Women: Identification and Fracture Outcomes of Undiagnosed

C. Chesnut, 2010 .

The relationship between skeletal and oral bone mineral density: an overview.

C. Chesnut, 2001, Annals of periodontology.

Implementation of an osteoporosis research program with a mobile dual-energy X-ray absorptiometry unit: The Montana/Wyoming experience

C. Chesnut, M. Browning, U. Ulrich, 2007, Osteoporosis International.

Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin.

C. Chesnut, D. Baylink, J. Farley, 1981, Clinical chemistry.

Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.

W. Nelp, H. Gruber, C. Chesnut, 1983, Metabolism: clinical and experimental.

The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.

C. Rosen, C. Chesnut, N. Mallinak, 1997, The Journal of clinical endocrinology and metabolism.

Urinary N‐Telopeptides to Monitor Bone Resorption While on GnRH Agonist Therapy

W. Dmowski, C. Chesnut, L. Marshall, 1996, Obstetrics and gynecology.

Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling.

H. Genant, P. Delmas, K. Ensrud, 1995, The American journal of medicine.

The role of skeletal calcium deficiency in postmenopausal osteoporosis

J. Burnell, C. Chesnut, D. Baylink, 1986, Calcified Tissue International.

Review of calcitonin-present: current status of calcitonin as a therapeutic agent.

C. Chesnut, 1992, Bone and mineral.

Osteoporotic bone fragility. Detection by ultrasound transmission velocity.

R R Recker, R. Recker, L. Avioli, 1989, JAMA.

Menstrual history as a determinant of current bone density in young athletes.

B L Drinkwater, B. Drinkwater, C. Chesnut, 1990, JAMA.

Bone density changes during pregnancy and lactation in active women: a longitudinal study.

B. Drinkwater, C. Chesnut, B. L. Drinkwater, 1991, Bone and mineral.

Tiludronate: development as an osteoporosis therapy.

C. Chesnut, C H Chesnut, 1995, Bone.

Bone mineral density after resumption of menses in amenorrheic athletes.

B L Drinkwater, B. Drinkwater, S. Ott, 1986, JAMA.

Theoretical overview: bone development, peak bone mass, bone loss, and fracture risk.

C. Chesnut, 1991, The American journal of medicine.

Bone mineral content of amenorrheic and eumenorrheic athletes.

W J Bremner, B L Drinkwater, B. Drinkwater, 1984, The New England journal of medicine.

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol.

W. Hazzard, S. Haffner, J. Albers, 1984, Biochimica et biophysica acta.

Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.

W. Nelp, C. Chesnut, J. Denney, 1977, Metabolism: clinical and experimental.

Evaluation of intravenous calcium as therapy for osteoporosis.

W. Nelp, D. Sherrard, C. Chesnut, 1973, The American journal of medicine.

Bone mineral content of amenorrheic and eumenorrheic athletes

B. Drinkwater, W. Bremner, C. Chesnut, 1985 .

Bone density changes during pregnancy and lactation in active women: a longitudinal study

B. Drinkwater, C. Chesnut, 1992 .

Treatment of Postmenopausal Osteoporosis: Some Current Concepts

C. Chesnut, 1981, Scottish medical journal.

Longitudinal changes in bone mass after one year as measured by different techniques in patients with osteoporosis

S. Ott, C. Chesnut, R. Kilcoyne, 1986, Calcified Tissue International.

Osteoporosis: some aspects of pathophysiology and therapy.

C. Chesnut, P. Kribbs, 1982, The Journal of prosthetic dentistry.

Relationships between mandibular and skeletal bone in an osteoporotic population.

S. Ott, C. Chesnut, R. Kilcoyne, 1989, The Journal of prosthetic dentistry.

Site of bone density measurement may affect therapy decision

B. Drinkwater, C. Chesnut, M. Rencken, 1993, Calcified Tissue International.

Bone remodeling and bone mineral density during pregnancy

D. Eyre, M. Soules, C. Chesnut, 2003, Archives of Gynecology and Obstetrics.

Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women

S. T. Harris, C. Chesnut, 1993, Osteoporosis International.

Short-term calcium supplementation has no effect on biochemical markers of bone remodeling in early postmenopausal women

D. Eyre, M. Soules, C. Chesnut, 2004, Archives of Gynecology and Obstetrics.

Quantitation of bone mass in osteoporosis: Recent advances

W. Nelp, T. Lewellen, C. Chesnut, 1975, Calcified Tissue Research.

articleSafety of bazedoxifene in a randomized , double-blind , placebo-and active-controlled phase 3 study of postmenopausal women with osteoporosis

Jacques P. Brown, C. Christiansen, J. Adachi, 2015 .

Oral findings in osteoporosis. Part II: Relationship between residual ridge and alveolar bone resorption and generalized skeletal osteopenia.

D. E. Smith, C. Chesnut, P. Kribbs, 1983, The Journal of prosthetic dentistry.

Bone density loss during treatment of chronic GVHD.

B. Bruemmer, C. Chesnut, J. Sanders, 1996, Bone Marrow Transplantation.

Absolute measurement of total-body calcium by the Ar-37 method-preliminary results: concise communication.

W. Nelp, T. Lewellen, C. Chesnut, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Elevated plasma low-density lipoprotein and high-density lipoprotein cholesterol levels in amenorrheic athletes: effects of endogenous hormone status and nutrient intake.

B. Drinkwater, A. Chait, B. Bruemmer, 1993, The Journal of clinical endocrinology and metabolism.

Total body calcium and long-term calcium balance in chronic renal disease.

W. Nelp, D. Sherrard, C. Chesnut, 1973, The Journal of laboratory and clinical medicine.

Women of reproductive age with endometriosis are not osteopenic.

C. Chesnut, U. Ulrich, M. Skinner, 1998, Fertility and sterility.

Outcomes of early ileocolectomy after percutaneous drainage for perforated ileocolic Crohn's disease.

W. Koltun, A. Berg, T. Connelly, 2016, American journal of surgery.

Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females.

V. Matkovic, C. Chesnut, P. Goel, 1990, The American journal of clinical nutrition.

Is osteoporosis a pediatric disease? Peak bone mass attainment in the adolescent female.

C. Chesnut, 1989, Public health reports.

ImprovedMethodfor QuantitativeDeterminationin Serumof Alkaline

C. Chesnut, D. Baylink, R. Farley, 2004 .

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

H. Genant, N. Watts, P. Miller, 1997, The American journal of medicine.

Total body bone mineral and lean body mass by dual-photon absorptiometry

W. Nelp, W. Peppler, S. Cohn, 2006, Calcified Tissue International.

Relationship between local and total bone mass in osteoporosis.

W. Nelp, J. Wergedal, C. Chesnut, 1975, Metabolism: clinical and experimental.

Nuclear medicine techniques in the evaluation of post menopausal osteo porosis

W. Nelp, T. Lewellen, C. Chesnut, 1976 .

Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis.

C. Chesnut, C H Chesnut, H. Gruber, 1986, Mineral and electrolyte metabolism.

Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

C. Christiansen, D. Felsenberg, P. Delmas, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Penetrating Cardiac Nail Gun Injury in a Child.

C. Chesnut, J. B. Clark, A. Kulaylat, 2016, Pediatric emergency care.

Salmon calcitonin: a review of current and future therapeutic indications

M. Olson, S. Silverman, S. Silverman, 2008, Osteoporosis International.

Denosumab in Postmenopausal Women with Low Bone Mineral Density

P. Miller, M. Peacock, M. McClung, 2007 .

Systemic osteoporosis and oral bone loss: evidence shows increased risk factors.

C. Chesnut, M. Jeffcoat, 1993, Journal of the American Dental Association.

A comparison of two dual-energy X-ray absorptiometry systems for spinal bone mineral measurement

M. Goodsitt, C. Chesnut, R. Murano, 1992, Calcified Tissue International.

Calcitriol treatment is not effective in postmenopausal osteoporosis.

S. Ott, C. Chesnut, 1989, Annals of internal medicine.

Osteoporosis and dental osteopenia in the elderly.

C. Chesnut, P. Kribbs, P. J. Kribbs, 1984, Gerodontology.

Relationships between mandibular and skeletal bone in a population of normal women.

S. Ott, C. Chesnut, R. Kilcoyne, 1990, The Journal of prosthetic dentistry.

The profile of successful applicants for endocrine surgery fellowships: results of a national survey.

C. Chesnut, A. Kulaylat, J. Schubart, 2014, American journal of surgery.

Oral Daily Ibandronate Prevents Bone Loss in Early Postmenopausal Women Without Osteoporosis

J. Cauley, K. Ensrud, R. Recker, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

B. Drinkwater, C. Rosen, N. Bell, 1997, The American journal of medicine.

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE

N. Watts, R. Recker, P. Miller, 2005, Current medical research and opinion.

Perspective: Reconsidering the Effects of Antiresorptive Therapies in Reducing Osteoporotic Fracture

C. Chesnut, C. Rosen, Charles H Chesnut, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Medical Treatment Of Osteoporosis

C. Chesnut, 1995 .

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

C. Christiansen, P. Delmas, R. Recker, 2004, Osteoporosis International.

Treating Osteoporosis with Bisphosphonates and Addressing Adherence

C. Chesnut, 2012, Drugs.

Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology.

D. Felsenberg, G. Armbrecht, G. von Ingersleben, 2008, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women.

H. Genant, K. Ensrud, M. McClung, 1997, The American journal of medicine.

Pathogenesis and treatment of postmenopausal osteoporosis

C. Christiansen, A. Parfitt, J. Reeve, 1983, Calcified Tissue International.

Mineral loss in the parenteral nutrition patient.

S. Ott, A. Chait, E. Lipkin, 1988, The American journal of clinical nutrition.

Comparisons among methods of measuring bone mass and relationship to severity of vertebral fractures in osteoporosis.

S. Ott, C. Chesnut, R. Kilcoyne, 1988, The Journal of clinical endocrinology and metabolism.

Ultrasound velocity through bone predicts incident vertebral deformity

R. Recker, L. Avioli, R. Heaney, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Can PET-CT Imaging and Radiokinetic Analyses Provide Useful Clinical Information on Atypical Femoral Shaft Fracture in Osteoporotic Patients?

C. Chesnut, C. Chesnut, C. H. I. Chesnut, 2012, Current Osteoporosis Reports.

Osteoporotic bone fragility. Detection by ultrasound transmission velocity

Robert P. Heaney, R. Recker, L. Avioli, 1989 .

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.

C. Christiansen, P. Delmas, R. Recker, 2004, Bone.

History of etidronate.

W. Mysiw, H. Genant, N. Watts, 2020, Bone.

Successful operative rib fixation of traumatic flail chest in a patient with osteogenesis imperfecta.

S. Armen, C. Chesnut, A. Kulaylat, 2014, Interactive cardiovascular and thoracic surgery.

Enhanced precision with dual-energy x-ray absorptiometry

H. Genant, R. Mazess, M. McClung, 1992, Calcified Tissue International.

Progression of Efficacy with Ibandronate

M. Zaidi, S. Epstein, S. T. Harris, 2007, Annals of the New York Academy of Sciences.

Cyclical etidronate treatment of postmenopausal osteoporosis: 4 year experience

H. Genant, N. Watts, P. Miller, 1992 .

A new set of calibration standards for estimating the fat and mineral content of vertebrae via dual energy QCT.

M. Goodsitt, C. Chesnut, R. Johnson, 1991, Bone and mineral.

In-vivo measurement of osteoporotic bone fragility with apparent velocity of ultrasound

R. Poss, G. Brandenburger, C. Chesnut, 1989, Proceedings., IEEE Ultrasonics Symposium,.

Bone mass and exercise.

C. Chesnut, 1993, The American journal of medicine.

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

P Geusens, H Zippel, P. Geusens, 2001, The New England journal of medicine.

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

N. Bell, C. Chesnut, M. Notelovitz, 1997, The American journal of medicine.

Osteoporosis, Fractures, and Thiazides

C. Chesnut, 1984, Journal of the American Geriatrics Society.

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

C. Chesnut, N. Mallinak, K. Flessland, 1997, The American journal of medicine.

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis

Jacques P. Brown, C. Christiansen, J. Adachi, 2010, BMC musculoskeletal disorders.

In-vivo Measurement Of Osteoporotic Bone Fragility With Apparent Velocity Of Ultrasound

G. Brandenburger, L. Avloli, C. Chesnut, 1990, [1990] Proceedings of the Twelfth Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Clinical Use of Biochemical Markers of Bone Remodeling: Current Status and Future Directions

D. C. Bauer, N. H. Bell, D. Bauer, 2000, Osteoporosis International.